Physical Evaluation Board Forum

Jason · #1 (**permalink**) January 20th, 2008

Diseases of the trachea and bronchi

Rating

6600 Bronchitis, chronic:

FEV-1 less than 40 percent of predicted value, or; the ratio of
Forced Expiratory Volume in one second to Forced Vital Capacity
(FEV-1/FVC) less than 40 percent, or; Diffusion Capacity of the
Lung for Carbon Monoxide by the Single Breath Method (DLCO
(SB)) less than 40-percent predicted, or; maximum exercise capacity
less than 15 ml/kg/min oxygen consumption (with cardiac or
respiratory limitation), or; cor pulmonale (right heart failure), or;
right ventricular hypertrophy, or; pulmonary hypertension (shown
by Echo or cardiac catheterization), or; episode(s) of acute
respiratory failure, or; requires outpatient oxygen therapy 100

FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to 55
percent, or; DLCO (SB) of 40- to 55-percent predicted, or;
maximum oxygen consumption of 15 to 20 ml/kg/min (with
cardiorespiratory limit) 60

FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to
70 percent, or; DLCO (SB) 56- to 65-percent predicted 30
FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to
80 percent, or; DLCO (SB) 66- to 80-percent predicted 10

6601 Bronchiectasis:

With incapacitating episodes of infection of at least six weeks total
duration per year 100

With incapacitating episodes of infection of four to six weeks total
duration per year, or; near constant findings of cough with
purulent sputum associated with anorexia, weight loss, and frank
hemoptysis and requiring antibiotic usage almost continuously 60

With incapacitating episodes of infection of two to four weeks total
duration per year, or; daily productive cough with sputum that is
at times purulent or blood-tinged and that requires prolonged (lasting
four to six weeks) antibiotic usage more than twice a year 30

Intermittent productive cough with acute infection requiring a course
of antibiotics at least twice a year 10

Or rate according to pulmonary impairment as for chronic bronchitis
(DC 6600).

Note: An incapacitating episode is one that requires bedrest and treatment by a physician.

6602 Asthma, bronchial:

FEV-1 less than 40-percent predicted, or; FEV-1/FVC less than
40 percent, or; more than one attack per week with episodes of
respiratory failure, or; requires daily use of systemic (oral or
parenteral) high dose corticosteroids or immuno-suppressive
medications 100

FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to
55 percent, or; at least monthly visits to a physician for required
care of exacerbations, or; intermittent (at least three per year)
courses of systemic (oral or parenteral) corticosteroids 60

FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to
70 percent, or; daily inhalational or oral bronchodilator therapy,
or; inhalational anti-inflammatory medication 30

FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to
80 percent, or; intermittent inhalational or oral bronchodilator therapy 10

Note: In the absence of clinical findings of asthma at time of examination, a verified history of asthmatic attacks must be of record.

6603 Emphysema, pulmonary:

FEV-1 less than 40 percent of predicted value, or; the ratio of Forced
Expiratory Volume in one second to Forced Vital Capacity
(FEV-1/FVC) less than 40 percent, or; Diffusion Capacity of the
Lung for Carbon Monoxide by the Single Breath Method (DLCO
(SB)) less than 40-percent predicted, or; maximum exercise capacity
less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory
limitation), or; cor pulmonale (right heart failure), or; right ventricular
hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac
catheterization), or; episode(s) of acute respiratory failure, or; requires
outpatient oxygen therapy. 100

FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to
55 percent, or; DLCO (SB) of 40- to 55-percent predicted, or;
maximum oxygen consumption of 15 to 20 ml/kg/min (with
cardiorespiratory limit) 60

FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to
70 percent, or; DLCO (SB) 56- to 65-percent predicted 30 FEV-1
of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to 80
percent, or; DLCO (SB) 66- to 80-percent predicted 10

6604 Chronic obstructive pulmonary disease:

FEV-1 less than 40 percent of predicted value, or; the ratio of
Forced Expiratory Volume in one second to Forced Vital Capacity
(FEV-1/FVC) less than 40 percent, or; Diffusion Capacity of the
Lung for Carbon Monoxide by the Single Breath Method (DLCO
(SB)) less than 40-percent predicted, or; maximum exercise capacity
less than 15 ml/kg/min oxygen consumption (with cardiac or
respiratory limitation), or; cor pulmonale (right heart failure), or;
right ventricular hypertrophy, or; pulmonary hypertension (shown
by Echo or cardiac catheterization), or; episode(s) of acute
respiratory failure, or; requires outpatient oxygen therapy. 100

FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to
55 percent, or; DLCO (SB) of 40- to 55-percent predicted, or;
maximum oxygen consumption of 15 to 20 ml/kg/min (with
cardiorespiratory limit) 60

FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to
70 percent, or; DLCO (SB) 56- to 65-percent predicted 30 FEV-1
of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to
80 percent, or; DLCO (SB) 66- to 80-percent predicted 10